Hospital-Acquired Infections Market - Type of Infection (Surgical Site Infections (SSIs), Urinary Tract Infections (UTIs), Pneumonia, Bloodstream Infections, Gastrointestinal Infections, Others), By Pathogen Type (Bacterial, Infections (Staphylococcus aureus, Escherichia coli), Viral Infections (Influenza, Norovirus) Fungal Infections (Candida spp.), Multidrug-Resistant Organisms (MDROs) (MRSA, VRE)), By Risk Factors (Surgical Procedures, Invasive Medical Devices (Catheters, Ventilators), Immunosuppression, Length of Hospital Stay, Antibiotic Resistance), By Treatment Modality (Antibiotic Therapy, Antiviral Therapy, Antifungal Therapy, Supportive Care), By End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Long-term Care Facilities), By Product Type (Disinfectants and Sterilization Products, Antibiotics and Antimicrobials, Diagnostic Tests, Vaccines, Others), and By Country (Japan, China, India, South Korea, Australia & NZ, ASEAN, Rest of Asia-Pacific)

$2400.00